A self-destructing vaccine administered intravenously provides additional safety and protection against tuberculosis (TB) in macaque monkeys, suggests new University of Pittsburgh research published ...

The in-built in protection mechanisms offer a safer and more effective way to combat the deadliest disease of 2024.

CG Oncology's stock has dropped 40% since its IPO peak, driven by profit-taking and competitive concerns despite promising ...

Scientists have developed a breakthrough mechanism that makes the intravenous Bacillus Calmette-Guérin (BCG) tuberculosis ...

Primrose Bio, Inc. ("Primrose"), a company with proprietary manufacturing technologies for human therapeutics, and Serum Institute of India Pvt. Ltd. ("SIIPL"), the world's largest vaccine ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in ...

The antibody treatment, sasanlimab, in combination with Bacillus Calmette-Guérin (BCG) vaccine met the main goal of the study ...

While unvaccinated macaque monkeys exhibited signs of severe lung inflammation and disease following the Mycobacterium  tuberculosis infection (warm colors indicate inflammation and disease, bottom ...

A new tuberculosis vaccine that self-destructs to enhance safety has shown promising results in macaque monkeys, providing ...